Details for Patent: 8,956,288

Which drugs does patent 8,956,288 protect, and when does it expire?

Patent 8,956,288 protects ABILIFY MYCITE KIT and is included in one NDA.

This patent has fifteen patent family members in nine countries.

Summary for Patent: 8,956,288

Title:	In-body power source having high surface area electrode
Abstract:	Power sources that enable in-body devices, such as implantable and ingestible devices, are provided. Aspects of the in-body power sources of the invention include a solid support, a first high surface area electrode and a second electrode. Embodiments of the in-power sources are configured to emit a detectable signal upon contact with a target physiological site. Also provided are methods of making and using the power sources of the invention.
Inventor(s):	Hafezi; Hooman (Redwood City, CA), Robertson; Timothy (Belmont, CA), Snyder; Eric (South San Francisco, CA), Cozad; Brad (Newark, CA)
Assignee:	Proteus Digital Health, Inc. (Redwood City, CA)
Application Number:	12/527,190
Patent Claim Types: see list of patent claims	Use; Composition; Device; Dosage form;

United States Patent 8,956,288: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 8,956,288, titled "In-body power source having high surface area electrode," is a significant innovation in the field of medical devices, particularly for implantable and ingestible devices. This patent, granted on February 17, 2015, addresses the critical need for efficient power sources within the human body.

Background and Motivation

The development of implantable and ingestible medical devices has been rapidly advancing, driven by the need for more effective and less invasive medical treatments. However, one of the major challenges is the reliable and efficient powering of these devices. Traditional power sources often fall short due to limitations in size, power density, and biocompatibility. The invention described in US Patent 8,956,288 aims to overcome these challenges by introducing a novel in-body power source design[1][5].

Scope of the Invention

The patent covers an in-body power source designed to power implantable and ingestible devices. The key components include:

High Surface Area Electrode

The invention features a high surface area electrode, which is crucial for increasing the power density and efficiency of the power source. This electrode is designed to maximize the surface area available for electrochemical reactions, thereby enhancing the overall performance of the device[1][5].

Solid Support

The power source includes a solid support that houses the electrodes. This support is engineered to be biocompatible and durable, ensuring the longevity and safety of the device within the human body[1][5].

Circuitry and Signal Processing

The patent also describes the circuitry and signal processing elements necessary for managing the power output and ensuring stable operation of the device. This includes mechanisms for controlling the flow of electrical current and processing signals generated by the power source[1].

Claims of the Patent

The patent includes several claims that define the scope of the invention:

Independent Claims

• Claim 1 describes the in-body power source with a high surface area electrode and a solid support.
• Claim 2 details the specific configuration of the electrodes and the solid support.
• Claim 3 outlines the circuitry and signal processing components[1].

Dependent Claims

• These claims further specify various aspects of the invention, such as the materials used for the electrodes, the design of the solid support, and additional features that enhance the functionality and safety of the power source[1].

Patent Landscape

The patent landscape surrounding US Patent 8,956,288 is complex and dynamic, reflecting the ongoing innovation in medical device technology.

Prior Art

The patent acknowledges prior art related to implantable power sources but distinguishes itself through the novel use of high surface area electrodes and specific design configurations. The prior art keywords listed include "electrode," "circuitry element," "signal," "layer," and "solid support," indicating the areas where the invention improves upon existing technologies[1].

Related Patents and Applications

Other patents and applications in the field of implantable and ingestible devices often focus on different aspects such as biocompatible materials, energy harvesting, and advanced circuitry. For example, research datasets provided by the USPTO can help identify trends and developments in patent claims related to medical devices, highlighting the evolving nature of this field[3].

Regulatory and Legal Considerations

The establishment and enforcement of patents in this domain are subject to rigorous legal and regulatory scrutiny. Initiatives such as the proposed small claims patent court study by the Administrative Conference of the United States (ACUS) aim to streamline the process of resolving patent disputes, which could impact the landscape for medical device patents[2].

Impact on Medical Device Technology

The invention described in US Patent 8,956,288 has significant implications for the development of advanced medical devices:

Enhanced Power Density

The high surface area electrode design allows for greater power density, enabling devices to operate more efficiently and for longer durations without the need for frequent recharging or replacement[1].

Improved Biocompatibility

The biocompatible nature of the solid support and other components ensures that the power source is safe for use within the human body, reducing the risk of adverse reactions or complications[1].

Expanded Applications

This technology can be applied to a wide range of implantable and ingestible devices, including pacemakers, neurostimulators, and diagnostic sensors, thereby expanding the scope of medical treatments available[1].

Future Directions and Challenges

While the patent represents a significant advancement, there are ongoing challenges and future directions to consider:

Technological Advancements

Continued research is needed to further enhance the efficiency, safety, and durability of in-body power sources. This includes exploring new materials and designs that can improve performance while reducing size and increasing biocompatibility.

Regulatory Compliance

Ensuring compliance with evolving regulatory standards is crucial. This involves staying updated with changes in patent laws, medical device regulations, and ethical guidelines.

Market Adoption

The adoption of this technology in clinical settings will depend on successful clinical trials, cost-effectiveness, and acceptance by medical professionals and patients.

Key Takeaways

• High Surface Area Electrode: The patent introduces a novel electrode design that enhances power density and efficiency.
• Biocompatible Design: The solid support and other components are engineered to be safe for use within the human body.
• Advanced Circuitry: The invention includes sophisticated circuitry and signal processing elements.
• Regulatory Considerations: The patent landscape is influenced by ongoing legal and regulatory developments.
• Future Directions: Continued innovation is necessary to address challenges and expand applications.

FAQs

Q: What is the primary innovation of US Patent 8,956,288?

A: The primary innovation is the use of a high surface area electrode to enhance the power density and efficiency of in-body power sources.

Q: What are the key components of the in-body power source described in the patent?

A: The key components include a high surface area electrode, a solid support, and advanced circuitry and signal processing elements.

Q: How does this patent impact the development of medical devices?

A: It enables the creation of more efficient, safe, and durable implantable and ingestible devices, expanding the scope of medical treatments available.

Q: What are some of the regulatory considerations for this patent?

A: The patent is subject to regulatory scrutiny, including compliance with medical device regulations and potential impacts from proposed changes in patent dispute resolution processes.

Q: What future directions are there for this technology?

A: Future research should focus on further enhancing efficiency, safety, and biocompatibility, as well as ensuring regulatory compliance and market adoption.

Sources

1. US Patent 8,956,288: In-body power source having high surface area electrode.
2. ACUS: U.S. Patent Small Claims Court study.
3. USPTO: Patent Claims Research Dataset.
4. USPTO: Search for patents.
5. US Patent Application US-2023157570-A1: In-body power source having high surface area electrode.

Drugs Protected by US Patent 8,956,288

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-001	Nov 13, 2017		RX	Yes	No	8,956,288		Y			METHOD OF USING A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-002	Nov 13, 2017		RX	Yes	Yes	8,956,288		Y			METHOD OF USING A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-003	Nov 13, 2017		RX	Yes	No	8,956,288		Y			METHOD OF USING A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-004	Nov 13, 2017		RX	Yes	No	8,956,288		Y			METHOD OF USING A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-005	Nov 13, 2017		RX	Yes	No	8,956,288		Y			METHOD OF USING A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-006	Nov 13, 2017		RX	Yes	No	8,956,288		Y			METHOD OF USING A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER

Foreign Priority and PCT Information for Patent: 8,956,288

PCT Information
PCT Filed	February 14, 2008	PCT Application Number:	PCT/US2008/053999
PCT Publication Date:	August 21, 2008	PCT Publication Number:	WO2008/101107

International Family Members for US Patent 8,956,288

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2008216170
Canada	2676280
Canada	3000257
China	101636865
China	103066226
European Patent Office	2111661
European Patent Office	3236524